
Kerala Ayurveda Ltd. (KERALAYUR) Share Price Near 52-Week Low: Stock Trades Within 2% of One-Year Bottom
Updated: 13 Aug 2026 • 1:33 pm
Posted by:

Kerala Ayurveda Ltd. Share Price stood at Rs 148 on 13 August 2026 and was trading within 2% of its 52-week low. The company’s market capitalisation was Rs 202.46 crore.
Kerala Ayurveda Ltd. Share Price was at Rs 148 at 1:31 PM IST on 13 August 2026, placing the stock within 2% of its 52-week low and valuing the company at a market capitalisation of Rs 202.46 crore. That makes Kerala Ayurveda Ltd. Share Price a stock in focus for traders and long-term market watchers tracking one-year bottom zones in smaller healthcare names.
The verified data confirms the price event, but it does not establish a company-specific catalyst behind the move. Even so, proximity to a yearly low often draws attention because it can reflect weak sentiment, a market reassessment of financial quality, or simply a prolonged phase of underperformance relative to broader listed peers. In this case, Kerala Ayurveda Ltd. Share Price is also being assessed against negative earnings, negative book value and deeply negative return ratios.
From a Univest screening perspective, the setup is relevant because Kerala Ayurveda Ltd. Share Price sits in a zone where valuation interpretation becomes more complex than in profitable peers. Investors following Kerala Ayurveda Ltd. Share Price Today are therefore likely to look beyond the headline price and examine whether the current level aligns with the company’s profitability profile, sector benchmarks and peer positioning.
Kerala Ayurveda Ltd. Share Price Today: Within 2% of 52-Week Low
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 148 |
| Market Capitalisation | Rs 202.46 crore |
| 52-Week Low Position | Trading within 2% of its 52-week low |
Kerala Ayurveda Ltd. (KERALAYUR) traded at Rs 148. Reported volume was 17,562.
Kerala Ayurveda Ltd. Share Price Today was Rs 148 at the event qualification timestamp of 1:31:18 PM IST, and the Univest screener identified the stock as trading within 2% of its 52-week low. That is the central verified price signal in today’s Kerala Ayurveda Ltd. Share Price News. The available data confirms the live traded level and its proximity to the one-year bottom, even though no exact reference low price has been supplied for publication.
For market participants, this kind of setup matters because stocks hovering near yearly lows often attract a different kind of attention than momentum names near highs. Kerala Ayurveda Ltd. Share Price is not being highlighted for breakout strength; it is being watched because price is operating close to a level that many investors associate with caution, reassessment and potential stress in expectations. In smaller-cap companies, such zones can become important reference points for sentiment.
The company’s market value of Rs 202.46 crore places it in the smaller listed end of the healthcare universe, which can sometimes amplify scrutiny when the stock is close to a one-year low. Univest data does not establish a specific event-led trigger today, so the move should be read as a factual market-position update rather than a confirmed reaction to any single development. With Kerala Ayurveda Ltd. Share Price near its yearly bottom, the next step is to examine whether the fundamentals justify heightened investor attention.
Kerala Ayurveda Ltd. (KERALAYUR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 202.46 crore |
| P/E Ratio | -7.25x |
| P/B Ratio | -16.89x |
| ROE | -183.03% |
| ROCE | -0.45% |
| EPS | Rs -20.41 |
| Book Value Per Share | Rs -9.31 |
| Dividend Yield | 0% |
Kerala Ayurveda Ltd. was valued at a P/E ratio of -7.25x, a P/B ratio of -16.89x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -183.03% and ROCE of -0.45%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs -20.41, book value per share of Rs -9.31, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | -7.25x |
| Benchmark Median P/E | 18.99x |
| Benchmark Average P/E | 52.65x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | -16.89x |
| Benchmark Median P/B | 1.82x |
| Company ROE | -183.03% |
| Benchmark Median ROE | 10.49% |
| Company ROCE | -0.45% |
| Benchmark Median ROCE | 12.97% |
| Company Market Capitalisation | Rs 202.46 crore |
| Benchmark Median Market Cap | Rs 146.46 crore |
Kerala Ayurveda Ltd. (KERALAYUR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -7.25x, which is below the benchmark median of 18.99x, a difference of -138.18%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kerala Ayurveda Ltd. (KERALAYUR) has a ROE of -183.03%, which is below the benchmark median of 10.49%, a difference of -1,844.8%. Kerala Ayurveda Ltd. (KERALAYUR) has a ROCE of -0.45%, which is below the benchmark median of 12.97%, a difference of -103.47%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Coral Laboratories Ltd. | CORALAB | 206.87 | 12.63 | 0.99 | 10.74 | 13.35 |
| Accretion Pharmaceuticals Ltd. | ACCPL-ST | 209.76 | 21.7 | 4.02 | 27.18 | 12.62 |
| Gennex Laboratories Ltd. | GENNE | 215.98 | 13.56 | 1 | 10.71 | 13.24 |
| Accretion Nutraveda Ltd. | ANL | 216.48 | 42.71 | 6.86 | 106.65 | 21.4 |
| BIO MEDICA LABORATORIES L | BMLL-SM | 182.4 | 15.63 | 10.06 | 13.67 | 10.17 |
Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -7.25x compared with the displayed peer median of 15.63x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -183.03% compares with a peer median of 13.67% across the companies shown in the table. ROCE stood at -0.45% versus the displayed peer median of 13.24%, providing a capital-efficiency comparison. Kerala Ayurveda Ltd. (KERALAYUR) has a market capitalisation of Rs 202.46 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Kerala Ayurveda Ltd.
- Kerala Ayurveda Ltd. Share Price is at Rs 148 and is trading within 2% of its 52-week low.
- The company’s market capitalisation is Rs 202.46 crore, keeping it on the radar among smaller healthcare stocks.
- P/E at -7.25, P/B at -16.89, EPS at -20.41 and book value at -9.31 point to pressure in conventional valuation and balance-sheet readings.
- ROE of -183.03 and ROCE of -0.45 sit well below industry median levels in Pharmaceuticals & Drugs.
- Peer companies with similar market caps mostly show positive P/E, ROE and ROCE, highlighting the contrast.
- Dividend yield is 0, so the stock is being watched mainly for price positioning and financial context rather than income support.
About Kerala Ayurveda Ltd.
Kerala Ayurveda Ltd. is a listed company classified under the Healthcare sector and the Pharmaceuticals & Drugs industry. In market classification terms, that places Kerala Ayurveda Ltd. Share Price in a segment that is typically evaluated using earnings, book value, return ratios and market-cap comparisons against other healthcare and pharmaceutical businesses.
Based on the supplied classification data, Kerala Ayurveda Ltd. operates within the same listed industry universe used for the 135-company benchmark referenced in this article. That benchmark context is important because it helps investors compare Kerala Ayurveda Ltd. Share Price with businesses that are grouped under the same industry label for valuation and profitability analysis.
At a market capitalisation of Rs 202.46 crore, the company sits above the industry median size but below the industry average. For readers tracking Kerala Ayurveda Ltd. Share Price News, that means the stock occupies a relevant position within the smaller end of the listed healthcare space, where financial ratios and peer comparisons often drive market attention when a stock moves close to its one-year low.
Track Kerala Ayurveda Ltd. Share Price on Univest
Use Kerala Ayurveda Ltd. (KERALAYUR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors tracking Kerala Ayurveda Ltd. Share Price can use Univest to monitor live price movement, 52-week levels, fundamental ratios, valuation trends, peer benchmarks and broader market insights. When a stock appears near a one-year bottom, having those data points in one place helps put the move in context.
Univest also allows users to follow Kerala Ayurveda Ltd. Share Price Today alongside sector comparisons, market capitalisation, profitability ratios and listed peer snapshots. For readers watching Kerala Ayurveda Ltd. Share Price News, that makes it easier to separate a simple price event from a broader change in financial positioning. Univest is especially useful when the focus shifts from headline moves to deeper ratio-based analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Kerala Ayurveda Ltd. Share Price today?
Ans. Kerala Ayurveda Ltd. Share Price was Rs 148 at 1:31:18 PM IST on 13 August 2026. The stock was identified by the Univest screener as trading within 2% of its 52-week low.
Why is Kerala Ayurveda Ltd. Share Price in focus today?
Ans. Kerala Ayurveda Ltd. Share Price is in focus because the stock is trading within 2% of its 52-week low. The company also has a market capitalisation of Rs 202.46 crore and weak profitability ratios.
What is the market capitalisation of Kerala Ayurveda Ltd.?
Ans. Kerala Ayurveda Ltd. has a market capitalisation of Rs 202.46 crore. That is above the Pharmaceuticals & Drugs industry median market cap of Rs 146.46 crore but below the industry average of Rs 492.80 crore.
Is Kerala Ayurveda Ltd. profitable based on the supplied data?
Ans. The supplied data shows negative profitability. Kerala Ayurveda Ltd. reports a P/E of -7.25, EPS of -20.41, ROE of -183.03 and ROCE of -0.45, indicating losses and weak return metrics.
What does the negative book value mean for Kerala Ayurveda Ltd.?
Ans. Kerala Ayurveda Ltd. has a book value per share of -9.31, which means the accounting net worth behind each share is negative on the supplied figures. Its P/B ratio is also negative at -16.89.
Does Kerala Ayurveda Ltd. offer a dividend yield?
Ans. The supplied dividend yield for Kerala Ayurveda Ltd. is 0. This means the current data does not show a running dividend yield support, so attention remains on price levels and financial ratios.
How does Kerala Ayurveda Ltd. compare with its industry P/E benchmark?
Ans. Kerala Ayurveda Ltd. has a P/E of -7.25 versus the same-industry median of 18.99 and average of 52.65 across 135 companies. That places it well below the profitable centre of the benchmark group.
How does Kerala Ayurveda Ltd. compare with similar listed peers?
Ans. Peers such as Coral Laboratories, Accretion Pharmaceuticals and Gennex Laboratories have positive P/E, ROE and ROCE figures, while Kerala Ayurveda Ltd. shows negative values on all three measures despite a similar market-cap range.
Which sector and industry does Kerala Ayurveda Ltd. belong to?
Ans. Kerala Ayurveda Ltd. is classified under the Healthcare sector and the Pharmaceuticals & Drugs industry. Its benchmark comparison in this article is drawn from the same industry universe of 135 companies.
Recent Articles

Nifty FMCG Today: Index Gains 0.84% to Close Near Day High
13 August 2026

Nifty 50 Today: Closing Bell Market Wrap for 13 August 2026
13 August 2026

Gopal Snacks Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
13 August 2026

Berger Paints India Ltd. (BERGEPAINT) Share Price Falls 3.02%: Price Action, Sector and Peer Analysis
13 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Nifty FMCG Today: Index Gains 0.84% to Close Near Day High
Nifty 50 Today: Closing Bell Market Wrap for 13 August 2026
Gopal Snacks Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Berger Paints India Ltd. (BERGEPAINT) Share Price Falls 3.02%: Price Action, Sector and Peer Analysis
Kalpataru Projects International Ltd. (KPIL) Share Price Falls 3.23% Today
Popular this week
City Union Bank Ltd. (CUB): City Union Bank Share Price Falls 4.26% to Rs 206.65, Emerges as Top Decliner

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





